GCS Ramsay Santé pour l'Enseignement et la Recherche
ramsaygds.frLive pipeline data from ClinicalTrials.gov, refreshed daily.
Total trials
233
Active
87
Phase 3
2
Total enrollment
94,024
Pipeline matrix
Showing 7 of 7 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| MORPHINE | — | — | — | — | 2 | ||
| Lidocaine IV | — | — | — | — | — | 1 | |
| 24 hours antibiotics | — | — | — | — | — | 1 | |
| 48 hours antibiotics | — | — | — | — | — | 1 | |
| Intravenous lidocaine administration | — | — | — | — | — | 1 | |
| Neuroleptanalgesia | — | — | — | — | — | 1 | |
| Neuroleptanalgesic treatment | — | — | — | — | — | 1 |
Next readouts
- 2026-01-18
- 2026-05-31
- 2026-11
- 2027-07-30
- 2027-08-31
Top conditions
- ACL - Anterior Cruciate Ligament Rupture7
- Prostate Cancer6
- Latarjet4
- Shoulder Injuries4
- Endometriosis4
- Analgesia4
- Knee Injuries3
- Gonarthrosis3
Frequently asked questions about GCS Ramsay Santé pour l'Enseignement et la Recherche
- How many clinical trials does GCS Ramsay Santé pour l'Enseignement et la Recherche have on ClinicalTrials.gov?
- GCS Ramsay Santé pour l'Enseignement et la Recherche is listed as the lead sponsor on 233 clinical trials in ClinicalTrials.gov, 87 of which are currently active (recruiting, enrolling, or ongoing).
- How many of GCS Ramsay Santé pour l'Enseignement et la Recherche's trials are in Phase 3?
- 2 of GCS Ramsay Santé pour l'Enseignement et la Recherche's trials are in Phase 3, spread across 7 active drug programs.
- What therapeutic areas does GCS Ramsay Santé pour l'Enseignement et la Recherche focus on?
- GCS Ramsay Santé pour l'Enseignement et la Recherche's most-studied conditions on ClinicalTrials.gov are ACL - Anterior Cruciate Ligament Rupture, Prostate Cancer, Latarjet, Shoulder Injuries, Endometriosis.
- When are GCS Ramsay Santé pour l'Enseignement et la Recherche's next clinical trial readouts?
- GCS Ramsay Santé pour l'Enseignement et la Recherche has 5 upcoming primary-completion readouts tracked here; the soonest is “Evaluation of the Benefit of Lidocaine on the Prevention of the Risk of Post Endoscopic Retrograde Cholangio-pancreatography Pancreatitis.”, expected around 2026-01-18.